Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

NYSE:CDRE - US12763L1052 - Common Stock

31 USD
+0.24 (+0.78%)
Last: 8/27/2025, 6:38:10 PM
31 USD
0 (0%)
After Hours: 8/27/2025, 6:38:10 PM
Fundamental Rating

6

CDRE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 68 industry peers in the Aerospace & Defense industry. CDRE has an excellent profitability rating, but there are some minor concerns on its financial health. CDRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CDRE was profitable.
CDRE had a positive operating cash flow in the past year.
Each year in the past 5 years CDRE has been profitable.
In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of CDRE (4.80%) is better than 67.65% of its industry peers.
CDRE's Return On Equity of 11.46% is fine compared to the rest of the industry. CDRE outperforms 76.47% of its industry peers.
With a decent Return On Invested Capital value of 7.10%, CDRE is doing good in the industry, outperforming 66.18% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CDRE is in line with the industry average of 8.40%.
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROIC 7.1%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

The Profit Margin of CDRE (6.65%) is better than 67.65% of its industry peers.
CDRE's Profit Margin has improved in the last couple of years.
The Operating Margin of CDRE (12.22%) is better than 80.88% of its industry peers.
CDRE's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 41.49%, CDRE belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDRE is destroying value.
The number of shares outstanding for CDRE has been increased compared to 1 year ago.
Compared to 5 years ago, CDRE has more shares outstanding
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CDRE has an Altman-Z score of 3.09. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
CDRE has a Altman-Z score of 3.09. This is comparable to the rest of the industry: CDRE outperforms 47.06% of its industry peers.
CDRE has a debt to FCF ratio of 9.51. This is a negative value and a sign of low solvency as CDRE would need 9.51 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 9.51, CDRE is doing good in the industry, outperforming 63.24% of the companies in the same industry.
A Debt/Equity ratio of 0.91 indicates that CDRE is somewhat dependend on debt financing.
The Debt to Equity ratio of CDRE (0.91) is worse than 72.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Altman-Z 3.09
ROIC/WACC0.71
WACC9.93%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CDRE has a Current Ratio of 3.59. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.59, CDRE is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
A Quick Ratio of 2.56 indicates that CDRE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.56, CDRE is doing good in the industry, outperforming 76.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 2.56
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CDRE have decreased by -8.74% in the last year.
The Earnings Per Share has been growing by 34.28% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 7.66% in the past year.
CDRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.17% yearly.
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%

3.2 Future

CDRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.48% yearly.
CDRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue Next Year11.34%
Revenue Next 2Y9.44%
Revenue Next 3Y8.99%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.98, CDRE can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 70.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.14, CDRE is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 21.66, the valuation of CDRE can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 75.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (22.80), we can say CDRE is valued inline with the index average.
Industry RankSector Rank
PE 32.98
Fwd PE 21.66
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CDRE is valued a bit cheaper than the industry average as 79.41% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CDRE is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 37.69
EV/EBITDA 16.57
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CDRE may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 19.48% in the coming years.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y26.11%
EPS Next 3Y19.48%

More info and screens

4

5. Dividend

5.1 Amount

CDRE has a Yearly Dividend Yield of 1.28%.
CDRE's Dividend Yield is rather good when compared to the industry average which is at 1.18. CDRE pays more dividend than 88.24% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CDRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

38.92% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP38.92%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

More info and screens

CADRE HOLDINGS INC

NYSE:CDRE (8/27/2025, 6:38:10 PM)

After market: 31 0 (0%)

31

+0.24 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners69.4%
Inst Owner Change-0.36%
Ins Owners30.6%
Ins Owner Change0.15%
Market Cap1.26B
Analysts80
Price Target39.27 (26.68%)
Short Float %7.65%
Short Ratio6.49
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP38.92%
Div Incr Years1
Div Non Decr Years3
Ex-Date08-01 2025-08-01 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.6%
Min EPS beat(2)11.29%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)27.62%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)20.75%
EPS beat(12)8
Avg EPS beat(12)16%
EPS beat(16)10
Avg EPS beat(16)32.32%
Revenue beat(2)2
Avg Revenue beat(2)2.38%
Min Revenue beat(2)0.27%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)4.48%
Revenue beat(8)6
Avg Revenue beat(8)0.05%
Revenue beat(12)9
Avg Revenue beat(12)0.71%
Revenue beat(16)11
Avg Revenue beat(16)0.59%
PT rev (1m)-9.77%
PT rev (3m)-7%
EPS NQ rev (1m)-19.82%
EPS NQ rev (3m)-21.21%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)-4.8%
Revenue NQ rev (3m)9.81%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 32.98
Fwd PE 21.66
P/S 2.2
P/FCF 37.69
P/OCF 32.76
P/B 3.79
P/tB 39.9
EV/EBITDA 16.57
EPS(TTM)0.94
EY3.03%
EPS(NY)1.43
Fwd EY4.62%
FCF(TTM)0.82
FCFY2.65%
OCF(TTM)0.95
OCFY3.05%
SpS14.08
BVpS8.18
TBVpS0.78
PEG (NY)0.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROCE 10.17%
ROIC 7.1%
ROICexc 8.87%
ROICexgc 19.55%
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
FCFM 5.84%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexcg growth 3Y-11.18%
ROICexcg growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Debt/EBITDA 3.49
Cap/Depr 30.73%
Cap/Sales 0.88%
Interest Coverage 4.33
Cash Conversion 44.54%
Profit Quality 87.78%
Current Ratio 3.59
Quick Ratio 2.56
Altman-Z 3.09
F-Score5
WACC9.93%
ROIC/WACC0.71
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%
Revenue Next Year11.34%
Revenue Next 2Y9.44%
Revenue Next 3Y8.99%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year76.73%
EBIT Next 3Y30.01%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y-22.52%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%